Lung Cancer clinical trials

496 recruiting studies in the US for lung cancer, cancer that begins in the lungs.

Lung cancer trials are mostly Phase 1 and 2 treatment studies, often built around tumor mutations such as EGFR, ALK or KRAS, along with immunotherapy combinations. Screening usually asks for biopsy results, recent scans and a list of prior treatments. Screening and early-detection studies are also available for people at high risk.